Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value ($000): $155,341 (100.0% shares, 0.0% debt)

Holdings (8)

— REVANCE THERAPEUTICS INC 31.8%

Value ($000) $49,462 Shares 3,342,047 Est. Cost $31.50 Unrealized —

— EYEPOINT PHARMACEUTICALS INC 27.5%

Value ($000) $42,747 Shares 41,909,219 Est. Cost $1.64 Unrealized —

AXGN AXOGEN INC 16.3%

Value ($000) $25,272 Shares 2,429,999 Est. Cost $4.01 Unrealized +217.8%

— VENUS CONCEPT, INC. 16.0%

Value ($000) $24,913 Shares 7,017,856 Est. Cost $4.70 Unrealized —

TELA TELA BIO, INC. 5.4%

Value ($000) $8,400 Shares 1,074,231 Est. Cost $12.59 Unrealized +7.3%

MNOV MEDICINOVA INC 2.6%

Value ($000) $4,114 Shares 1,105,941 Est. Cost $2.95 Unrealized +76.4%

— CATALYST BIOSCIENCES INC 0.2%

Value ($000) $344 Shares 78,622 Est. Cost $7.36 Unrealized —

— ENDOLOGIX INC 0.1%

Value ($000) $89 Shares 125,747 Est. Cost $11.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	3,342,047	$49,462	31.8%	$31.50	—	COM	761330109
—	EYEPOINT PHARMACEUTICALS INC	41,909,219	$42,747	27.5%	$1.64	—	COM	30233G100
AXGN	AXOGEN INC	2,429,999	$25,272	16.3%	$4.01	+217.8%	COM	05463X106
—	VENUS CONCEPT, INC.	7,017,856	$24,913	16.0%	$4.70	—	COM	92332W105
TELA	TELA BIO, INC.	1,074,231	$8,400	5.4%	$12.59	+7.3%	COM	872381108
MNOV	MEDICINOVA INC	1,105,941	$4,114	2.6%	$2.95	+76.4%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$344	0.2%	$7.36	—	COM NEW	14888D208
—	ENDOLOGIX INC	125,747	$89	0.1%	$11.05	—	COM NEW	29266S304